neurocrine.com (NBIX) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Neurocrine Biosciences - NBIX emitenti grafik logotipi

Neurocrine Biosciences (NBIX) uchun ushbu kunlik narxlar grafigi noyob asab tizimi patologiyalari terapiyasi nishasida ortib borayotgan talabga asoslangan bo'lib, u yerda ko'rsatkich 0.11 darajasida turibdi. Biroq, biznes yagona mahsulotga bog'liqligi va hukumatning qat'iy narx nazorati tufayli zaif bo'lib qolmoqda. Kompaniyaning moliyaviy muvaffaqiyati uning asosiy daromad generatori bo'lib xizmat qiluvchi patentlangan INGREZZA dori vositasining global taqsimotiga bog'liq.

Neurocrine (NBIX): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 01.11.2026gacha

Neurocrine Biosciences kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Neurocrine|NBIX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Neurocrine Biosciences, Inc.|NBIX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Neurocrine Biosciences|NBIX - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati neurocrine.com|NBIX - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Neurocrine Biosciences|NBIX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi neurocrine.com|NBIX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Neurocrine Biosciences, Inc.|NBIX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Neurocrine Biosciences|Oraliq qoplash koeffitsiyenti neurocrine.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
NBIX - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:NBIX (Neurocrine)
Neurocrine original mahsuloti

Neurocrine Biosciences (NBIX) kompaniyasida biofarmatsevtika ta'minot zanjirlarining barqarorligi kompaniyaga operatsion uzilishlar xavfisiz uzoq muddatli majburiyatlarni samarali boshqarish imkonini beradi. Uzoq muddatli qarzning kapitalga nisbati tarixini tahlil qilish orqali investor bir yildan ortiq muddatli kreditlarning sof aktivlarga nisbatdagi ulushini baholaydi, bu esa moliyaviy leveraj va haddan tashqari konservativlik natijasida yo'qotilgan foyda xavfi o'rtasidagi muvozanatni belgilaydi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati RGC|AXSM - Uzoq muddatli majburiyatlarning kapitalga nisbati|ACADIA Pharmaceuticals - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati xenon-pharma.com XENE|VKTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Denali Corp (DNLI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Harmony Biosciences|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BHVN (biohavenpharma.com)|Uzoq muddatli qarzning kapitalga nisbati AMLX|TRVI - Uzoq muddatli majburiyatlarning kapitalga nisbati|Praxis Medicines - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Anavex Life Sciences Corp AVXL|CBLL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRTA (Prothena Corporation PLC)|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Annexon Biosciences (ANNX)|OMER (Omeros Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Therapeutics (NGNE)|Uzoq muddatli qarzning o'z kapitaliga nisbati AC Immune (ACIU)|VYGR (voyagertherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati NMRA (Neumora Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Scilex Holding (SCLX)|TVGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACOG (Alpha Cognition) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CGTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati inhibikase.com (IKT)|Uzoq muddatli qarzning o'z kapitaliga nisbati SAVA|ASRT: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning o'z kapitaliga nisbati VTGN (vistagen.com)|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati acumenpharm.com (ABOS)|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alterity Therapeutics|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PEPG - Uzoq muddatli qarzdorlikning kapitalga nisbati|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning kapitalga nisbati ANVS|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|ANEW Medical (KLTO) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH (revivapharma.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis Inc.|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Passage Bio Corp PASG|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning kapitalga nisbati|KTTA - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRGT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Trevena Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati